Zach Rozenbaum is a Cardiology physician affiliated with Tulane University. OpenAlex indexes 136 publications with 1,390 citations (h-index 18); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1430 Tulane Ave # 8548
New Orleans, LA 701122632
Telephone
504-988-3522Provider last certified this registry record 26 Mar 2022.
Clinical trials
- Ultra-Low Contrast Angiography in AKI
Sponsor: Tulane University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
19 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year202514 payments
- Edwards Lifesciences CorporationProgram year20253 payments
- Medtronic, Inc.Program year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
71.2%Loop diuretic12.4%Furosemide100%Part D≥13 patientsBeta blocker11.6%Metoprolol Succinate59%Carvedilol41%Part D<11 patients+ 6 more classes in this area
Blood & clotting
28.8%P2Y12 inhibitor16.3%Clopidogrel100%Part D≥15 patientsFactor Xa inhibitor12.4%Eliquis100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Mortality-Based Right Ventricle Functional Echocardiographic Cutoffs in Patients With Compared to Without Tricuspid Regurgitation
Journal of the American Society of Echocardiography
2024 - Sex differences in heart failure patients assessed by combined echocardiographic and cardiopulmonary exercise testing
Frontiers in Cardiovascular Medicine
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Erik Castle, MD
Tulane University
John Schieffelin, MD
Tulane University
Thierry Lejemtel, MD
Tulane University
Robert Hendel, MD
Tulane University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”